학술논문

Extended follow-up from JAVELIN Renal 101: subgroup analysis of avelumab plus axitinib versus sunitinib by the International Metastatic Renal Cell Carcinoma Database Consortium risk group in patients with advanced renal cell carcinoma
Document Type
Article
Source
In ESMO Open June 2023 8(3)
Subject
Language
ISSN
2059-7029